ImpactLife Appoints New Chief Medical Officer; Dr. Louis Katz will become emeritus | Local News

Dr. Louis Katz, ImpactLife’s longtime chief medical officer, is moving to emeritus status effective July 1.

Dr. Daniela Hermelin will replace him, the blood center announced Thursday.

Hermelin is an assistant professor of pathology at St. Louis University School of Medicine and medical director of transfusion services at SSM Health St. Louis University Hospital and SSM Health Cardinal Glennon Children’s Hospital, according to a news release. She is also the social media editor for Transfusion Medicine Reviews and associate editor of The Blood Bank Guy Essentials podcast and Transfusion News.

“We are very fortunate to introduce Dr. Daniela Hermelin as our new Chief Medical Officer,” said Mike Parejko, President and CEO of ImpactLife. “She is a highly regarded specialist in transfusion medicine who brings a wealth of experience from her previous roles at Saint Louis University and SSM Health. I have great confidence in her ability to succeed Dr. Louis Katz in this role of essential leadership.”

People also read…

Katz began his medical career as an infectious disease specialist and deeply involved in the treatment of HIV/AIDS patients since the onset of the pandemic in the early 1980s. He was appointed chief medical officer of what was then known as the Mississippi Valley Regional Blood Center in 1983. He is the medical director of the Scott County Department of Public Health — a role he will continue, county health officials said.

He is also an Adjunct Clinical Professor of Infectious Diseases at the University of Iowa Healthcare, Chief Medical Officer of the US Blood Centers, and Medical Director of The Project (a regional HIV/AIDS service organization).